Literature DB >> 15464187

Analysis of 2000 consecutive UK tonsillectomy specimens for disease-related prion protein.

Adam Frosh1, Lorraine C Smith, Carl J Jackson, Jacqueline M Linehan, Sebastian Brandner, Jonathan D F Wadsworth, John Collinge.   

Abstract

Variant Creutzfeldt-Jakob disease (CJD) is thought to be caused by dietary or other exposure to bovine spongiform encephalopathy (BSE) prions. The prevalence of preclinical or subclinical prion infection in the UK is currently unknown. Since clinical variant CJD is uniformly associated with tonsillar prion infection, we screened 2000 anonymous surgical tonsillectomy specimens for disease-associated prion protein. Analysis by both high sensitivity immunoblotting and immunohistochemistry detected no positive cases. However, this negative result cannot provide reassurance that relevant community infection is unlikely because of the fairly small sample size, demographic and age-related factors, and unknown test sensitivity during the prolonged incubation period. Nevertheless, our findings establish a protocol for prevalence screening on a national scale.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15464187     DOI: 10.1016/S0140-6736(04)17143-2

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  22 in total

1.  Sensitivity of protein misfolding cyclic amplification versus immunohistochemistry in ante-mortem detection of chronic wasting disease.

Authors:  Nicholas J Haley; Candace K Mathiason; Scott Carver; Glenn C Telling; Mark D Zabel; Edward A Hoover
Journal:  J Gen Virol       Date:  2012-01-25       Impact factor: 3.891

2.  High levels of disease related prion protein in the ileum in variant Creutzfeldt-Jakob disease.

Authors:  S Joiner; J M Linehan; S Brandner; J D F Wadsworth; J Collinge
Journal:  Gut       Date:  2005-10       Impact factor: 23.059

Review 3.  Molecular neurology of prion disease.

Authors:  J Collinge
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07       Impact factor: 10.154

4.  Recent medical devices for tonsillectomy.

Authors:  I Sayin; C Cingi
Journal:  Hippokratia       Date:  2012-01       Impact factor: 0.471

Review 5.  Ethical considerations in presymptomatic testing for variant CJD.

Authors:  R E Duncan; M B Delatycki; S J Collins; A Boyd; C L Masters; J Savulescu
Journal:  J Med Ethics       Date:  2005-11       Impact factor: 2.903

6.  A multicentre audit of single-use surgical instruments (SUSI) for tonsillectomy and adenoidectomy.

Authors:  P O'Flynn; S Silva; P Kothari; R Persaud
Journal:  Ann R Coll Surg Engl       Date:  2007-09       Impact factor: 1.891

7.  Detection of proteinase K resistant proteins in the urine of patients with Creutzfeldt-Jakob and other neurodegenerative diseases.

Authors:  Reza Dabaghian; Inga Zerr; Uta Heinemann; Gianluigi Zanusso
Journal:  Prion       Date:  2008 Oct-Dec       Impact factor: 3.931

8.  Kuru prions and sporadic Creutzfeldt-Jakob disease prions have equivalent transmission properties in transgenic and wild-type mice.

Authors:  Jonathan D F Wadsworth; Susan Joiner; Jacqueline M Linehan; Melanie Desbruslais; Katie Fox; Sharon Cooper; Sabrina Cronier; Emmanuel A Asante; Simon Mead; Sebastian Brandner; Andrew F Hill; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-03       Impact factor: 11.205

9.  Dissociation of pathological and molecular phenotype of variant Creutzfeldt-Jakob disease in transgenic human prion protein 129 heterozygous mice.

Authors:  Emmanuel A Asante; Jacqueline M Linehan; Ian Gowland; Susan Joiner; Katie Fox; Sharon Cooper; Olufumilayo Osiguwa; Michelle Gorry; Julie Welch; Richard Houghton; Melanie Desbruslais; Sebastian Brandner; Jonathan D F Wadsworth; John Collinge
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-29       Impact factor: 11.205

10.  Prevalence of disease related prion protein in anonymous tonsil specimens in Britain: cross sectional opportunistic survey.

Authors:  Jonathan P Clewley; Carole M Kelly; Nick Andrews; Kelly Vogliqi; Gary Mallinson; Maria Kaisar; David A Hilton; James W Ironside; Philip Edwards; Linda M McCardle; Diane L Ritchie; Reza Dabaghian; Helen E Ambrose; O Noel Gill
Journal:  BMJ       Date:  2009-05-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.